Our Founder Story
For more than seventy years, protection from X-ray radiation has stagnated, with companies offering only modified shield designs and more lead armor. Radiaction Medical has pursued an entirely new model with Radiaction, a device that attaches to the C-arm to stop scatter radiation at the source. Based in Tel Aviv, Israel, it was founded in 2016 by a physician and accomplished innovator, Amir Belson, MD, whose goal is to ensure that every aspect of its technology places physicians and clinical staff first.
Our Mission
Engineering excellence allows us to surmount real-world challenges and limitations to make a lasting impact. Radiaction Medical draws on medical expertise and high-powered engineering to reduce the serious health risks the entire interventional staff now faces from daily radiation exposure while treating patients. One system protects all.
Our Product
In a complete departure from current solutions that shield or clothe users to block radiation, the company created Radiaction, a plug-and-play accessory to C-arm systems that blocks over 90% of scatter radiation at the source, offering head-to-toe protection for everyone in the room. Radiaction carries CE marking and FDA clearance and is currently marketed in North America and the European Union (EU).
Our Leadership
Jonathan Yifat
Dr. Amir Belson MD
Remo Almog
Jonathan Yifat
Since its inception, Mr. Yifat has led Radiaction, from concept to product, through regulation and quality, to fundraising and business development. With over 12 years of experience in R&D management, Jonathan has a unique mix of hands-on experience and strategic overview.
Before Radiaction, Jonathan was director of the R&D team in the Ballistic Missile Defense field at WALES Ltd, heading cutting-edge studies for Departments of Defense of various countries.
Jonathan received his BSc in Physics and Business Administration and MSc in Bio-Medical Engineering, all with honors, from Tel Aviv University.
Mr. Yifat was a regular keynote speaker at professional conferences worldwide and published several papers and patents in missile defense and medical technologies.
Dr. Amir Belson MD
Amir Belson, M.D., founded Neoguide Systems, which Intuitive Surgical acquired in 2009. Vascular Pathways, a vascular intervention technology acquired by C R Bard. Zipline Medical, a wound closure technology company, was acquired by Stryker. Qool Therapeutics is a minimally invasive therapeutic hypothermia technology company. Radiaction Medical is a radiation protection medical device company. Emboline, which develops proprietary embolic protection technology. Modular Surgical develops new minimally invasive surgery technology, and PAFA develops atrial fibrillation ablation technology.
Dr. Belson also serves as a board director of Relimetrics and QT Vascular.
Belson graduated cum laude from the school of medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. He did his pediatric residency at Dana Children’s Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford University. Belson also spent one year as a research fellow with Stanford's Biomedical Technology Innovation Program.
He is the author of 34 medical papers and abstracts and has more than 500 issued and pending patents.
Remo Almog
Mr. Almog has over 18 years of extensive experience leading R&D and Operations teams in medical devices. During his career, Almog has gained vast experience with the full product life cycle, including responsibility for product definition, product development, and product manufacturing in cardiovascular and multidisciplinary companies.
Almog held executive positions at Eximo medical, which was acquired by Angiodynamics (served as the company’s COO); MValve technologies (served as a Director of R&D); Valve Medical (served as an R&D team leader) and Corassist cardiovascular (served as R&D engineer).
Mr. Almog holds a B.Sc. in Mechanical Engineering from Ben Gurion University and an M.Sc in Mechanical Engineering and Management from Tel Aviv University.
Hila Angel
Steve Lotz
Amanda Bloom
Hila Angel
Hila joins the executive leadership team bringing vast finance experience to a variety of organizations ranging from publicly traded companies to startups. She has spent her career managing the financial aspects of several businesses, including accounting, FP&A, reporting, and process implementation. Hila excels in managing and optimizing company business processes and is extremely organized and diligent. Hila is inspired by the Radiaction mission and joined us because she wanted to work on an innovative and dynamic team.
Hila is a CPA with a B.A. in Accounting, a B.A. in Economics & Business Management, and an LL.M., Master of Laws, from Bar-Ilan University.
Steve Lotz
Steve has a 20-year track record of bringing transformative technologies to market and building outstanding sales management teams. He most recently served as VP of Sales at ZipLine Medical, Inc., where he built and led the sales team from commercialization to a successful acquisition by Stryker Corporation. Before ZipLine, Steve held key sales management roles at Knee Creations (now Zimmer Biomet), PEAK Surgical (now Medtronic), and ArthroCare Medical (now Smith+Nephew).
Steve has a BS in Biology from the University of South Florida.
Amanda Bloom
Amanda has nearly 20 years of up-and-downstream product management and marketing leadership experience in medical devices. In addition to leading and building strong product, marketing, clinical, and professional education teams, she has a proven track record of success in powering novel new product development, product launches, and product education programs, in addition to leading branding, channel, and digital marketing programs to drive market awareness, conversion, and adoption.
Before Radiaction, she served as VP of Product, Marketing, and Professional Education at Avail Medsystems. She built the team, programs, and processes to drive market adoption of their Surgical Telepresence platform, a burgeoning new market. Before that, Amanda held marketing leadership roles at Zimmer Biomet’s Robotic division, Nuvasive, a minimally invasive spine technology company where she managed their flagship portfolio, and Depuy Synthes.
Amanda managed and developed products and strategies for first-in-market technologies during these positions. Amanda has a BS in Biopsychology and a Minor in Communication Studies from Tufts University.
Lead Investor
